References list
1. Fehr T, Cippà PE, Mueller NJ. Cytomegalovirus post kidney
transplantation: prophylaxis versus pre-emptive therapy? Transplant Int.
2015;28(12):1351-1356. doi:10.1111/tri.12640.
2. Santos CA. Cytomegalovirus and Other β-Herpesviruses. Semin Nephrol.
2016;36(5):351–361.
3. Tufano A, Contaldi P, Coppola A, Nardo A, Franco N, Cerbone AM, Minno
GD. Cytomegalovirus-Associated Splanchnic Vein Thrombosis in
Immunocompetent Patients: Two Case Reports and Literature Review. Semin
Thromb Hemost. 2018;44(3):298–303.
4. Hotta K, Fukasawa Y, Wada Y, Fukuzawa N, Seki T, Harada H.
Cytomegalovirus peritonitis after kidney transplantation diagnosed
through histopathological examination. Transpl Infect Dis.
2017;19(4):e12708. doi:10.1111/tid.12708.
5. Nuansri S, Kantachuvesiri S, Watcharananan SP, Thongprayoon C,
Cheungpasitporn W, Bruminhent J. Clinical Characteristics of Late-Onset
Cytomegalovirus Infection After Kidney Transplantation. Transplant Proc.
2021;53(7):2267-2271.
6. Azevedo LS, Pierrotti LC, Abdala E, Costa SF, Strabelli TM, Campos
SV, Ramos JF, Latif AZ, Litvinov N, Maluf NZ, Caiaffa Filho HH, Pannuti
CS, Lopes MH, Santos VA, Linardi CdaC, Yasuda MA, Marques HH.
Cytomegalovirus infection in transplant recipients. Clinics (Sao Paulo,
Brazil). 2015;70(7):515–523.
7. Ceccarelli M, Venanzi Rullo E, Nunnari G. Risk factors of venous
thrombo-embolism during cytomegalovirus infection in immunocompetent
individuals: A systematic review. Eur J Clin Microbiol Infect Dis.
2018;37(3):381–390.
8. Wang L, Hsu Y, Sharma N. Thrombosis associated with Cytomegalovirus
(CMV) in a kidney transplant recipient. Cureus. 2021;13(9):e17745.
doi:10.7759/cureus.17745.
9. Pleško J, Kovač D, Arsov Z, Lindič J, Škoberne A, Ferluga D, Kojc N.
Glomerular and tubulointerstitial foscarnet nephropathy of kidney
allograft with emphasis on ultrastructural findings: A case report. Clin
Nephrol. 2021;96(1):127–132. doi:10.5414/CNP96S23.
10. Harrison C, Scull MA. Antiviral drug discovery: A personal
retrospective. Antiviral Res. 2019;167:104-112.
doi:10.1016/j.antiviral.2019.06.004.
11. Liu Y, Liang Y, Zhang J, Han R. The association between social
support and anxiety/depression among renal transplant recipients during
the COVID-19 outbreak: A cross-sectional online survey. Transpl Infect
Dis. 2020;22(6):e13441. doi:10.1111/tid.13441.
12. Rahman M, Griffin RL. Secondary hyperparathyroidism:
Pathophysiology, diagnosis, and treatment. Nephrology. 2017;22(3):88-98.
doi:10.1111/nep.12767.
13. de Souza JA, Gonçalves R, Zanetta DMT. Nursing workload in a renal
transplant unit: A cross-sectional study. J Bras Nefrol.
2019;41(1):76-83. doi:10.1590/2175-8239-jbn-2018-0012.
14. Johnston O, Rose CL. The ethics of renal transplantation. Am J
Kidney Dis. 2020;75(6):936-943. doi:10.1053/j.ajkd.2019.10.010.
15. Al-Malki T, Alharthi S. Renal transplantation in children: An
updated review. Pediatr Transplant. 2020;24(6):e13538.
doi:10.1111/petr.13538.
16. Mehraban D, Seraj M. Treatment adherence and its affecting factors
in kidney transplant recipients in Iran. Int Urol Nephrol.
2012;44(5):1297-1303. doi:10.1007/s11255-012-0293-y.
17. Lora AM, Khine J, Khosrodad N, Yeldandi V. Unusual manifestations of
acute cytomegalovirus infection in solid organ transplant hosts: A
report of two cases. Case Rep Transplant. 2017;2017:4916973.
doi:10.1155/2017/4916973.
18. Falagas ME, Vouloumanou EK. Antibiotic treatment of infections
caused by carbapenem-resistant Gram-negative bacteria: Systematic
evaluation of the available evidence. Infection. 2014;42(2):163-173.
doi:10.1007/s15010-014-0714-1.
19. Musiał K, Zwolińska D, Polak-Jonkisz D. Current status of pediatric
pancreas transplantation. Ann Transplant. 2015;20:444-450.
doi:10.12659/AOT.892076.
20. Ayvazoglu Soy EH, Moray G, Sönmez MG, Haberal M. Comparison of the
efficacy and safety of basiliximab versus thymoglobulin induction
therapy in live donor renal transplant recipients: A single-center
experience. Transplant Proc. 2017;49(3):457-460.
doi:10.1016/j.transproceed.2017.02.046.
21. Moray G, Ayvazoglu Soy EH, Sönmez MG, Haberal M. Comparison of the
efficacy and safety of basiliximab and thymoglobulin induction therapy
in deceased donor renal transplant recipients. Transplant Proc.
2017;49(8):1773-1779. doi:10.1016/j.transproceed.2017.09.058.
22. de Freitas JS, Kummer AM, Salomão JB, Borba HHL. Clinical and
histological aspects of chronic allograft nephropathy in kidney
transplant recipients. J Bras Nefrol. 2020;42(3):263-270.
doi:10.1590/2175-8239-JBN-2020-0254.
23. Baid-Agrawal S, Halloran PF. Immunosuppressive drugs in kidney
transplantation: Impact on patient survival, and incidence of
cardiovascular disease, malignancy and infection. Drugs.
2015;75(4):437-450. doi:10.1007/s40265-015-0365-5.
24. Naciri Bennani H, Wissing KM, Abramowicz D. Long-term medical
complications in renal transplant recipients: Experience from a single
center. Transplant Proc. 2014;46(6):1895-1901.
doi:10.1016/j.transproceed.2014.03.081.
25. Gomes IB, de Lourdes Aguiar Oliveira M, de Castro MCA. Infection
prevention and control in solid organ transplantation. Transpl Infect
Dis. 2014;16(3):353-367. doi:10.1111/tid.12105.
26. Hailat AQ. Attitudes toward organ donation among university students
in Jordan. J Public Health. 2017;25(4):387-392.
doi:10.1007/s10389-017-0771-7.
27. Kim YK, Kim JK, Park KM, Chung WH. Analysis of the efficacy and
safety of a calcineurin inhibitor-free immunosuppressive protocol in
kidney transplant recipients with hepatitis C virus infection.
Transplant Proc. 2016;48(5):1585-1590.
doi:10.1016/j.transproceed.2016.02.036.
28. Akoh JA. Perioperative management of the obese surgical patient. J
Perioper Pract. 2016;26(5):92-96. doi:10.1177/1203475416650643.
29. Borg MA, Zarb P, Scicluna EA, Rasslan O, Gür D, Ben Redjeb S. The
impact of enhanced infection control at a tertiary care hospital - a
decade of experience reducing healthcare associated infections. BMC
Infect Dis. 2014;14:259. doi:10.1186/1471-2334-14-259.
30. Iwai T, Uchida J, Kosoku A, Kabei K, Nishide S, Naganuma T, Maeda K,
Yoshikawa Y, Kumada N, Takemoto Y, Nakatani T. Splenectomy for
ABO-Incompatible Kidney Transplantation and Very Late-Onset
Cytomegalovirus Disease. Urol Int. 2020;104(7-8):651–656.
31. Bhasin H, Patel N, Arachchi A. Pyomyositis in a diabetic patient: A
rare case report. BMJ Case Rep. 2020;13(1):e231662.
doi:10.1136/bcr-2019-231662.
32. Katsube O, Kitamura T, Maruyama K. A case of IgG4-related disease
with multiple lung nodules. Intern Med. 2017;56(23):3173-3176.
doi:10.2169/internalmedicine.8815-17.
33. Sforza D, Iaria G, Tariciotti L, Manuelli M, Anselmo A, Ciano P,
Tisone G. Deep vein thrombosis as debut of cytomegalovirus infection
associated with type II cryoglobulinemia, with antierythrocyte
specificity in a kidney transplant recipient: A case report. Transplant
Proc. 2013;45(7):2782-2784. doi:10.1016/j.transproceed.2013.07.055.